Company Encyclopedia
View More
name
Bavarian Nordic A/S
BVNRY.US
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase III clinical trial for the treatment of SARS-CoV-2. The company has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service.
1.935 T
BVNRY.USMarket value -Rank by Market Cap -/-

Financial Score

27/12/2025 Update
B
BiotechnologyIndustry
Industry Ranking34/401
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE20.51%A
    • Profit Margin35.50%A
    • Gross Margin49.76%B
  • Growth ScoreB
    • Revenue YoY15.94%B
    • Net Profit YoY123.36%A
    • Total Assets YoY14.05%B
    • Net Assets YoY29.24%A
  • Cash ScoreB
    • Cash Flow Margin281.67%C
    • OCF YoY15.94%B
  • Operating ScoreC
    • Turnover0.47C
  • Debt ScoreA
    • Gearing Ratio13.20%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Bavarian Nordic Launches Long-term Incentive Program for Management and Employees

    Bavarian Nordic A/S has launched a long-term incentive program for its Executive Management and selected employees. The program includes 104,009 performance restricted stock units for executives, vesting in three years if key performance indicators are met, and 1,270,820 warrants for employees, exercisable in 2029 and 2030. The initiative aims to align management and employee interests with company performance.

    Reuters·
    US
    BVNRY
    +2.41%
    Reuters·
    US
    BVNRY
    +2.41%

    Heidi Hunter is named the new Vice Chair of Bavarian Nordic's Board, overseeing strategic decisions.

    In the latest reports, it has been disclosed that the unemployment rate in the country has risen to 6.2%, with 9.8 million people currently out of work. Additionally, the GDP growth forecast for the upcoming year has been revised to 3.5%, marking a significant decrease from the initial projection. The stock market also experienced a notable decline, with the major indexes dropping by 2.5% on average. These economic indicators suggest that the country may be facing some challenges in the near future.

    Unusual Whales·
    US
    BVNRY
    +2.41%
    Unusual Whales·
    US
    BVNRY
    +2.41%

    Heidi Hunter Named Vice Chair of Bavarian Nordic Board

    Bavarian Nordic A/S has appointed Heidi Hunter as Vice Chair of its Board of Directors, following Anne Louise Eberhard's appointment as Chair. Hunter will continue her roles on the Nomination and Compensation Committee and the Science and Technology Committee. The company is seeking additional board candidates for its annual general meeting in April 2026. This news was generated by Public Technologies using AI and is for informational purposes only.

    Reuters·
    US
    BVNRY
    +2.41%
    Reuters·
    US
    BVNRY
    +2.41%

    Bavarian Nordic A/S Announces Share Buy-back Program of up to DKK 500 Million

    Bavarian Nordic A/S announced a share buy-back program of up to DKK 500 million over the next 12 months. The repurchased shares will be held as treasury stock to adjust the capital structure. The program is authorized by shareholders and follows safe harbour regulations. Currently, Bavarian Nordic holds 966,845 treasury shares, 1.22% of its share capital.

    Reuters·
    US
    BVNRY
    +2.41%
    Reuters·
    US
    BVNRY
    +2.41%

    Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen

    Bavarian Nordic invites shareholders to an information meeting with board and management on Dec 11, 09:00-10:30 CET in Copenhagen. Register by Dec 9.

    GlobeNewswire·
    US
    BVNRY
    +2.41%
    GlobeNewswire·
    US
    BVNRY
    +2.41%
    © 2025 Longbridge｜Disclaimer